Bridge Pharma, Inc.
34Patents
22Active
34Granted
44Portfolio score
Filing activity: Sep 23, 1997 → Feb 17, 2021 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6207684A | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use | Human Necessities | 47 | Expired |
| US6123961A | Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin | Human Necessities | 27 | Expired |
| US7718674B2 | Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine | Human Necessities | 22 | Active |
| US7226934B1 | Optically active isomers of ketotifen and therapeutically active metabolites thereof | Human Necessities | 20 | Expired |
| US6207683A | Benzocycloheptathiophene compounds | Human Necessities | 16 | Expired |
| US8557846B1 | Medicinal treatment of dermal diseases in dogs | Human Necessities | 13 | Active |
| US7723392B2 | Use of RR/SR-ractopamine | Chemistry; Metallurgy | 12 | Active |
| US7557128B2 | Optically active isomers of ketotifen and therapeutically active metabolites thereof | Human Necessities | 12 | Active |
| US6110974A | Methods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the same | Human Necessities | 12 | Expired |
| US6432446B1 | Non-arrhythmogenic metabolite of oxybutynin | Human Necessities | 11 | Expired |
| US9138431B2 | Methods of treatment of histamine H-4 receptor-related pruritus | Human Necessities | 10 | Active |
| US6974820B2 | Methods for treating urinary incontinence and other disorders using trospium | Human Necessities | 8 | Expired |
| US9345697B2 | Methods of treatment of non-histaminic pruritus | Human Necessities | 8 | Active |
| US8765787B2 | Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen | Human Necessities | 7 | Active |
| US6413987B1 | Dermal anesthetic agents | Chemistry; Metallurgy | 7 | Expired |
| US9333199B2 | Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders | Human Necessities | 6 | Active |
| US6372799B1 | Non-sedating diphenhydramine metabolites | Human Necessities | 6 | Expired |
| US6207852A | Smooth muscle spasmolytic agents, compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Expired |
| US6310103A | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | Chemistry; Metallurgy | 4 | Expired |
| US7141696B2 | Smooth muscle spasmolytic agents | Human Necessities | 3 | Expired |
| US7985775B2 | Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals | Human Necessities | 3 | Active |
| US7390816B2 | Methods for treating urinary incontinence in patients suffering from memory disorders | Human Necessities | 3 | Active |
| US8969385B2 | Ocular formulations of norketotifen | Human Necessities | 3 | Active |
| US8071653B2 | Use of RR/SR-ractopamine | Chemistry; Metallurgy | 1 | Active |
| US8741930B2 | Treating xerophthalmia with norketotifen | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.